secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001625297-25-000042
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior appoints Tony Kingsley to board; directors adopt equity purchase plan
------------------------------------------------------------------------------

- Appointed Tony Kingsley as independent non-executive director effective July 1, 2025.
- Kingsley appointed per Oaktree relationship agreement; former CEO of Scholar Rock and Stablix.
- Five US non-executive directors entered JP Morgan purchase plan; company funds ~70% of after-tax retainer into shares.
- UK director Juliet Thompson bought 1,925 shares on June 11; company to reimburse over next year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000042/0001625297-25-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000042/indv-20250620.htm
  HTML page:      https://secwatch.observer/filing/0001625297-25-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer